Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. (Q43967323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

6

Marilyn M Wagener

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

Nina Singh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Shahid Husain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Donald R Carrigan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Konstance K Knox

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Timothy Gayowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

Clinical Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

92-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Human herpesvirus 6 in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Hepatitis C in Patients Undergoing Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Cytokines and fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

Serum levels of cytokines in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

In Vitro Suppression of Bone Marrow Progenitor Cell Differentiation by Human Herpesvirus 6 Infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

CYTOMEGALOVIRUS ANTIGENEMIA DIRECTED PRE-EMPTIVE PROPHYLAXIS WITH ORAL VERSUS I.V. GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

In vitro sensitivity of human herpesvirus-6 to antiviral drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

Susceptibility of human herpesvirus 6 to antivirals in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2002.1O096.X

7 January 2021

10.1034/J.1399-0012.2002.1O096.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966777%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference